Error loading player: No playable sources found
Applications in Advanced Analytical Technologies to Rapidly Deliver Well Characterized Biologics to Patients
Date
January 25, 2022
This product is not available for individual purchase, but it is available as part of the following products:
Continued progress in the development of sensitive and high-resolution analytical technologies have enabled significant progress towards the goal of a Well Characterized Biological Product. These advances allow for detailed characterization of biotherapeutic modalities even as the structural complexity of these modalities increase. Additionally, rapid analytical methods with equivalent or better sensitivity and precision are replacing methodologies requiring longer lead-times, ensuring quicker patient access to lifesaving therapies.
This session will focus on the current state of the art technologies utilized for product release and characterization, and how these technologies have evolved over time to accommodate product characterization of complex modalities with increased structural resolution.
This session will focus on the current state of the art technologies utilized for product release and characterization, and how these technologies have evolved over time to accommodate product characterization of complex modalities with increased structural resolution.
Session Chairs
Speakers
Pfizer, Inc.
CBER, FDA
General
Tracks
Related Products
Speed to Patients - Factory of the Future / Agile Manufacturing and Testing
This session is a continuation of Wednesday’s Speed to Patient Plenary Session. This session includes talks on novel strategies for manufacturing and testing products. It will also include a session from the EMA to discuss opportunities to gain approval for these novel strategies…
“Alone We Can Do So Little, Together We Can Do So Much” - How Did 25 Years of WCBP Conferences Shape Our Thinking and Our Way of Working?
“Alone we can do so little, together we can do so much” is a Helen Keller quote which captures the spirit of CASSS-organized conferences like WCBP, the regional CMC strategy forums, and technology specific meetings…
We Share Our Planet - Options to Remove Animals and/or Animal- derived Reagents from Release Testing
Use of animals and/or animal derived products to demonstrate safety or efficacy supports drug development and, in some cases, is required by law to release drug product…
